What it does
E-vita is a health supplement that may support overall wellness.
Commonly used for: general health improvement, boosting energy levels
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.
Sourcing - Kenya onlyRegistration & product details
Source: Pharmacy and Medicines Regulatory Authority · fetched 2026-04-21 17:37:42 · updated 2026-09-29 04:33:05
About this medicine
E-vita is a health supplement that may support overall wellness.
What it treats
- general health improvement
- boosting energy levels
How it works
E-vita is believed to enhance bodily functions and support vitality.
Who it's for
It is suitable for adults looking to improve their general health and energy.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: evita
Evita, also known as etanercept, is a recombinant protein that inhibits tumor necrosis factor (TNF), a key cytokine involved in systemic inflammation. It is primarily used in the treatment of autoimmune diseases such as rheumatoid arthritis, psoriasis, and ankylosing spondylitis. By blocking TNF, Evita reduces inflammation and slows disease progression.
Indications
- Rheumatoid arthritis
- Psoriatic arthritis
- Ankylosing spondylitis
- Plaque psoriasis
- Juvenile idiopathic arthritis
Dosage
Children: Dosage in paediatric patients should be determined based on the specific condition and patient characteristics. Refer to the BNF for Children for accurate dosing guidelines.
Adults: For adults, the typical dosing regimen varies based on the condition being treated. Refer to specific clinical guidelines and the BNF for detailed dosing information.
Mechanism of action
Evita acts as a TNF inhibitor by binding to soluble and membrane-bound TNF, preventing it from interacting with its receptors. This action leads to a decrease in the inflammatory response associated with various autoimmune conditions. It also modulates other pathways involved in the inflammatory process.
Pharmacodynamics
The pharmacodynamic effects of Evita include the reduction of inflammation, alleviation of pain, and improvement in physical function in patients with inflammatory diseases. It reduces the levels of inflammatory markers and cytokines, contributing to its therapeutic effects.
Pharmacokinetics
Evita is administered subcutaneously and has a bioavailability of approximately 64%. It reaches peak plasma concentrations within 24 to 72 hours. The drug is metabolized by proteolytic enzymes and has a half-life of approximately 70 hours. Clearance is decreased in patients with renal impairment.
Pregnancy
The safety of evita during pregnancy has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus.
Breast-feeding
It is unknown if evita is excreted in human milk. Caution should be exercised when administering to a nursing woman.
Storage
Store at room temperature, away from light and moisture. Keep out of reach of children.
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.